The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProvexis Share News (PXS)

Share Price Information for Provexis (PXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.65
Bid: 0.60
Ask: 0.70
Change: 0.00 (0.00%)
Spread: 0.10 (16.667%)
Open: 0.65
High: 0.00
Low: 0.00
Prev. Close: 0.65
PXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Idox Surges On Dye & Durham Takeover Offer

Fri, 19th Feb 2021 11:23

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

----------

AIM - WINNERS

----------

Idox, up 17% at 72.00 pence, 12-month range 24.5p-79p. The management software provider says it received a possible cash offer from Toronto-based provider of cloud-based software Dye & Durham. Idox says the proposed price is 75 pence per Idox share. Idox currently has around 443.7 million shares in issue. Dye & Durham stresses that there "can be no certainty that an offer will be made".

----------

Focusrite, up 5.5% at 1,033.00p, 12-month range 335p-1,090p. The music and audio products group says demand has remained strong in the first half, leading to revenue expectations ahead of internal forecasts.

----------

Provexis, up 3.7% at 0.84p, 12-month range 0.36p-1.49p. The food technology company says it has raised GBP50,000 through the placing of 6.7 million shares at 0.75p each. Says it will use the total amount raised to support its international growth plans as it highlighted a new production run for its Fruitflow+ Omega-3 heart-health dietary supplement product is in the process of being commissioned.

----------

Fiske, up 1.6% at 66p, 12-month range 56p-70p. The stockbroker says its results for the half year show a marked improvement on the prior year. Revenue for the six months to the end of November 2020 grew by 11% year-on-year to GBP2.8 million. Fiske's commission revenue was up 5% on the prior year, while its investment management fees increased by 14%.

----------

Fevertree Drinks, up 0.9% at 2,398.00p, 12-month range, 888.4p-2,587p. UBS starts coverage on the tonic water maker at Buy. Fevertree is one of the biggest companies on AIM with a market value of GBP2.8 billion.

----------

AIM - LOSERS

----------

Horizonte Minerals, down 7.5% at 8.56p. The Brazil-focused nickel development firm says it raised around GBP18 million via the placing of 162.7 million shares at a price of 7.5p per placing share. The proceeds will be used to initiate specific early works and advance long-lead time items linked to the start of construction of the company's Araguaia ferro-nickel project in Brazil.

----------

Jangada Mines, down 6.3% at 9.60p, 12-month range 0.9p-12.44p. The natural resource company says it raised GBP1.3 million via a placing of 13.9 million shares at 9.0p each, which will allow it to continue development at its Brazilian vanadiam project.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
27 Sep 2018 13:33

Provexis Annual Loss Widens, Starts New Year On Positive Note

LONDON (Alliance News) - Provexis PLC reported Thursday that a big rise in share-based payments led to a slightly widened loss for the 2018 financial year.However, Provexis said it has made

Read more
4 Jul 2018 11:32

Provexis Appoints Frederic Boned As Non-Executive Director

LONDON (Alliance News) - Provexis PLC said Wednesday it appointed Frederic Boned as non-executive director with immediate effect.Currently, Boned is EMEA vice president of DSM's Human a

Read more
30 Dec 2016 07:53

Provexis Narrows Loss But Will Need To Raise Funds In Next 4 Months (ALLISS)

Read more
30 Dec 2016 07:18

Provexis boosts revenue and narrows loss

(ShareCast News) - Developer of the proprietary Fruitflow heart-health functional food ingredient Provexis posted its unaudited interim results for the six months to 30 September on Friday, with total revenue for the period of £0.12m. The AIM-traded company said that was a threefold increase from th

Read more
20 Dec 2016 09:04

Provexis reports positive results from Fruitflow tests

(ShareCast News) - Developer of the Fruitflow heart-health functional food ingredient Provexis updated the market on its collaboration agreement with the University of Oslo on Tuesday, undertaking further research into the relationship between Fruitflow and blood pressure regulation. The AIM-traded

Read more
18 Nov 2016 10:42

Provexis says partnership will widen use of Fruitflow

(ShareCast News) - Developer of the Fruitflow heart-health functional food product, Provexis, announced on Friday that the company's alliance partner for Fruitflow, DSM Nutritional Products, has entered into a strategic collaboration agreement for Fruitflow with BY-HEALTH Co, a substantial listed Ch

Read more
23 Sep 2016 15:05

UK Shareholder Meetings Calendar - Next 7 Days

Read more
29 Jun 2016 14:59

Provexis chairman joins possible fundraising

(ShareCast News) - Provexis, the developer and licenser of the proprietary Fruitflow heart health food ingredient, updated the market on its ongoing seeking of funding on Wednesday, with an uplift in interest thanks to its chairman. The AIM-traded firm had announced on 9 June that it was in late sta

Read more
29 Jun 2016 09:49

WINNERS & LOSERS SUMMARY: Investors Hammer Brammer For Profit Warning

Read more
29 Jun 2016 08:45

Provexis Launches New Product, Continues Fundraising Talks (ALLISS)

Read more
9 Jun 2016 13:38

Provexis In Late Stage Talks With Investors For Fundraising (ALLISS)

Read more
31 May 2016 10:51

Provexis Expects To Report "Another Strong Year Of Progress"

Read more
7 Jan 2016 17:15

DIRECTOR DEALINGS SUMMARY: Provexis Directors Buy 4.9 Million Shares

Read more
7 Jan 2016 15:04

DIRECTOR DEALINGS: Provexis Directors Buy 4.9 Million Shares

Read more
22 Dec 2015 11:22

Provexis Remains Positive On Outlook As Pretax Loss Widens Slightly

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.